newsfilter
← Latest News
GlobeNewswire·

NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in March

NAARDEN, the Netherlands and MIAMI, Feb. 25, 2026 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients